A patient with peptic ulcer disease (PUD) is prescribed Carafate (sucralfate). What is the primary action of this medication in managing PUD?

Rationale: A. Incorrect because sucralfate does not function as an antacid. It does not chemically neutralize stomach acid or significantly change gastric pH. Therefore, it does not relieve ulcer pain through acid neutralization. B. Incorrect because proton pump inhibitors (PPIs), such as omeprazole or pantoprazole, are responsible for inhibiting the hydrogen-potassium ATPase enzyme system to reduce gastric acid secretion. Sucralfate has no effect on acid production. C. Incorrect because sucralfate does not affect gastric motility or emptying. Medications that influence gastric emptying, such as prokinetic agents, work through different mechanisms. D. Correct because sucralfate is a mucosal protectant. When it comes into contact with gastric acid, it forms a thick, viscous gel that adheres to the ulcer or erosion. This coating acts as a physical barrier, protecting the damaged mucosa from further injury caused by acid, pepsin, and bile salts. This allows the ulcer to heal over time. Sucralfate is especially useful for stress ulcers, duodenal ulcers, and gastric ulcers, and it has minimal systemic absorption, which reduces the risk of systemic side effects.